Dr. Ming Xu is the deputy director of the National Key Laboratory of Vascular Steady State and Reconstruction, the director of the Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides National Health Commission; the chairman of the Cardiovascular Professional Committee of the Chinese Society of Pathophysiology, the vice Dean of Peking University Graduate School. He is the editor in Chief of Book "Parents: The Best Health Managers for Children"; Dr. Xu participated in the writing of "Expert Consensus on Cardiac Aging Markers (2023)" and "Chinese Expert Consensus on Diagnosis and Treatment of Hypertensive Nephropathy (2022)". Dr. Xu’s representative achievements have been published in academic journals such as Circulation Research, Cardiovascular Research, Nature Metabolism, and Nucleic Acid Research. He conducted investigations on heart failure and cardiac remodeling and developmental programming and metabolic regulation through exercise intervention.
Dr. Junjie Xiao is the executive dean of the School of Life Science, Shanghai University, China. In addition, he is the director of the Key Laboratory of Biomedical Materials and Technology for Organ Regeneration of the Ministry of Education, the director of the Shanghai Organ Regeneration Engineering Technology Research Centre, and the head of the Cardiovascular Research Institute of Shanghai University. He is an Associate Editor of Journal of Molecular and Cellular Cardiology and Journal of Cardiovascular Translational Research, and is on the editorial boards of several other notable journals. He has authored or co-authored in journals such as Cell Metabolism, Circulation, Circulation Research, and Nature Communications, etc. His research focuses on heart failure intervention and risk prediction, with a particular emphasis on exercise-induced cardiac regeneration and the identification of novel therapeutic targets. He is also interested in epigenetic and metabolic regulations of cardiac function upon exercise and under pathological conditions.